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cells may then be accelerated by other
hyperplastic agents such as bladder calculi
which, though they may not be able to
substitute for promoters in the early stages
of conversion of an initiated cell into a latent
tumour cell, will propagate subsequent tum-
our growth by stimulating the rate of cell
turnover in the transformed urothelium.
Berenblum noted: 1. that for an unequivo-
cal demonstration of a second, promoting
stage ofcarcinogenesis, the initiating carcino-
gen must be used at a dose which is not car-
cinogenic to any marked degree; 2. that
tumour incidence is related to the dose of
initiator, not to the dose ofpromoter; 3. that
initiation requires only brief exposure to the
carcinogen and that the change produced is
persistent; and 4. that promotion requires
prolonged application of the promoter, and
is reversible in its early stages.
These observations were made on the basis
ofmouse skin, but are also demonstrably true
for carcinogenesis in the urinary bladder.
Thus: 1. The effect of initiation with either
MNU or FANFT, used at threshold or sub-
threshold doses, is promoted by subsequent
prolonged feeding of saccharin or cyclamate
in the diet (Hicks et al., 1978; Cohen et al.,
1979). If, however, MNU is used at a dose
which produces a 40% incidence of bladder
tumours, no increase in tumour incidence is
produced by ingestion ofsweeteners, although
in the same experiment a 28% incidence of
urothelial tumours of the renal pelvis was
promoted to 57% by saccharin and to 43°%
by cyclamate (Mohr et al., 1978). This is
directly analogous to observations made with
mouse skin which showed that the tumour
incidence following a high carcinogenic dose
of benzo(a)pyrene could not be increased by
subsequent application of the promoter
croton oil (Berenblum, 1941). 2. In the blad-
der, after one particular sub-threshold initiat-
ing dose of MNU, the tumour incidence is
constant at - 50% following promotion with
either dietary saccharin or cyclamate, ir-
respective of the dose of sweetener (Hicks
et al., 1978). 3. For initiation with MNU, all
that is required is a single, intravesicle instal-
lation ofa low dose (- 0-2 mg) which, because
of the rate of spontaneous decomposition in
the body, probably persists in the bladder for
not more than 20-30 min. Initiation with
MNU has now been demonstrated to persist
for at least 6 months, and with FANFT for
at least 6 weeks, though with the latter com-
pound there is some reduction in the sub-
sequent tumour incidence which follows
promotion, suggesting the presence of effec-
tive excision repair in the urothelium. 4. No
promotion was obtained with a single dose of
cyclophosphamide after initiation with MNU
(Hicks et al., 1978) but prolonged dosing with
cyclophosphamide promoted tumour growth
following initiation with FANFT (Cohen
et al., 1979).
These findings, together with other experi-
mental data now available, support the hypo-
thesis that carcinogenesis in the urinary
bladder, as in the mouse skin, is a multi-stage
process involving initiation, promotion and
propagation.
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A WIDE RANGE of proliferative lesions has
been observed in the livers of both rats and
mice. The lesions range from undoubted
hepatocarcinomas to small foci of prolifera-
tive hepatocytes. Many lesions may occur
"spontaneously", whilst similar effects have
been described after chemical injury, dietary
manipulation or surgical intervention.506 BRITISH ASSOCIATION FOR CANCER RESEARCH
Undoubted carcinomas can be recognized
with confidence in both the rat (Stewart &
Snell, 1959) and the mouse (Vesselinovitch
et al., 1978). Such lesions are associated with
the expected biological properties of invasion
and metastasis. The incidence of metastasis
in well-documented studies is similar in rats,
mice and men.
There remain many problems of inter-
pretation offocal proliferative lesions in both
rats and mice. In mice, both from treated
and control animals, foci of proliferative
parenchymal cells may be observed ranging
in size from a few cells to large macroscopic
nodules. They have a structure often resem-
bling normal liver, and residual portal tracts
may be present. The cytological features
show considerable pleomorphism, which is
compound related (Jones & Butler, 1975).
These lesions are not associated with invasion
and metastasis, but have been considered to
be "hepatomas", adenomas, carcinomas or
focal nodular hyperplasia. There is no evi-
dence that the lesions are malignant; hence
the differential diagnosis rests between
hyperplasia and benign neoplasia. As in
humans, the differential diagnosis of benign
neoplasm and hyperplasia cannot be made
with certainty.
In rats a wide range ofproliferative lesions
have been studied. Many may be induced by
known carcinogens, and consist of foci of
proliferating hepatocytes with starvation-
resistant glycogen in an otherwise struc-
turally normal liver (Butler, 1976). These
foci show a variable pattern of histochemical
enzyme depletion, and in some instances a
positive reaction for glutamyl transpeptidase.
These foci may be present at the time an
irreversible change has been induced by
agents such as the nitrosamines (Bannasch,
1968) and aflatoxin.
Other lesions that have been extensively
studied are those induced by 2-AAF. On
cyclical feeding at high doses a nodular liver
is observed which will subsequently develop
hepatocarcinoma (Teebor & Becker, 1971). It
was observed that unless nodules considered
to be hyperplastic were induced, carcinoma
was not subsequently observed. This observa-
tion supported the hypothesis that hyper-
plasia progressed to carcinoma. In conjunc-
tion with the description of the starvation-
resistant glycogen foci, these observations
lead to the designation of such lesions as
"neoplastic nodules". It is considered, in
view of the observation that the "nodules"
may be induced by non-carcinogens, surgical
intervention and dietary manipulation, that
the term "neoplastic nodule" is a misnomer,
and until further information is obtained as
to their biological behaviour they should not
be considered hyperplastic. Such nodules are
not transplantable (Williams et al., 1977).
Considerable debate continues as to the
significance of such observations. The weight
placed on such lesions considerably modifies
the predictive value of carcinogenesis studies.
In general a compound should not be
considered a carcinogen in a test species unless
one is confident that malignant neoplasm is
induced. The hypothesis that certain pro-
liferative foci progress to malignant neoplasm
is at present only a hypothesis. Such hypo-
theses are of value in elucidating mechanism,
but have little place in assessing the carcino-
genicity of compounds ofunknown biological
activity. In the absence of unequivocal
malignant neoplasia, and in a test of which
only the focal proliferative lesions described
in this paper are reported, a conclusion that
the compound under test is a carcinogen is
without foundation.
At present certain compounds, for example
some chlorinated pesticides, have been con-
sidered to be carcinogens on the basis of
lesions which do not satisfy the conventional
criteria for malignant neoplasia (Butler &
Jones, 1978). It is suggested that if more
rigorous criteria were adopted in assessing
such chronic pathological effects, a better
correlation would exist both between species
and other test systems, thus improving the
predictive value ofcurrenttests in recognizing
a hazard.
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